National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 269195

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 269195
Age:
Gender:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2006-12-14
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - - / -

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested.


Changed on 1/5/2010

VAERS ID: 269195 Before After
Age:(blank) 26.0
Gender:Female
Location:Unknown North Carolina
Vaccinated:0000-00-00 2006-09-08
Onset:0000-00-00 2006-09-08
Submitted:2006-12-14 2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - 0800F / - 1 - UN / - UN

Administered by: Other Private      Purchased by: Other Private
Symptoms: Injection site pain, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No Yes
ER or Doctor Visit? Yes No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006. Initial and follow up information has been received from a vaccine coordinator concerning a 26 year old female who on 08-SEP-2006 was vaccinated in the left deltoid with the second 0.5 mL dose of GARDASIL (Lot # 654540/0800F). On 08-SEP-2006, the injection site area filled up with fluid with tennis ball size swelling per the patient. It was reported that the duration was "a couple hours". It was previously reported that the patient had developed pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "


Changed on 7/31/2010

VAERS ID: 269195 Before After
Age:26.0
Gender:Female
Location:North Carolina
Vaccinated:2006-09-08
Onset:2006-09-08
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0800F / 1 UN / UN

Administered by: Private      Purchased by: Private
Symptoms: Injection site pain, Injection site swelling, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006. Initial and follow up information has been received from a vaccine coordinator concerning a 26 year old female who on 08-SEP-2006 was vaccinated in the left deltoid with the second 0.5 mL dose of GARDASIL (Lot # 654540/0800F). On 08-SEP-2006, the injection site area filled up with fluid with tennis ball size swelling per the patient. It was reported that the duration was "a couple hours". It was previously reported that the patient had developed pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "


Changed on 1/4/2011

VAERS ID: 269195 Before After
Age:26.0
Gender:Female
Location:North Carolina
Vaccinated:2006-09-08
Onset:2006-09-08
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0800F / 1 UN / UN

Administered by: Private      Purchased by: Private
Symptoms: Injection site pain, Injection site swelling, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006. Initial and follow up information has been received from a vaccine coordinator concerning a 26 year old female who on 08-SEP-2006 was vaccinated in the left deltoid with the second 0.5 mL dose of GARDASIL (Lot # 654540/0800F). On 08-SEP-2006, the injection site area filled up with fluid with tennis ball size swelling per the patient. It was reported that the duration was "a couple hours". It was previously reported that the patient had developed pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that " "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes". The patient stated that this "was not a big deal but preferred the injection in her leg". At the time of this report, the outcome of the events were unknown. Additional information has been requested.


Changed on 6/14/2014

VAERS ID: 269195 Before After
Age:26.0
Gender:Female
Location:North Carolina
Vaccinated:2006-09-08
Onset:2006-09-08
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0800F / 1 UN / UN

Administered by: Private      Purchased by: Private
Symptoms: Injection site pain, Injection site swelling, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006. Initial and follow up information has been received from a vaccine coordinator concerning a 26 year old female who on 08-SEP-2006 was vaccinated in the left deltoid with the second 0.5 mL dose of GARDASIL (Lot # 654540/0800F). On 08-SEP-2006, the injection site area filled up with fluid with tennis ball size swelling per the patient. It was reported that the duration was "a couple hours". It was previously reported that the patient had developed pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes". The patient stated that this "was not a big deal but preferred the injection in her leg". At the time of this report, the outcome of the events were unknown. Additional information has been requested.


Changed on 5/14/2017

VAERS ID: 269195 Before After
Age:26.0
Gender:Female
Location:North Carolina
Vaccinated:2006-09-08
Onset:2006-09-08
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0800F / 1 UN / UN

Administered by: Private      Purchased by: Private
Symptoms: Injection site pain, Injection site swelling, Wrong technique in drug usage process

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0611USA04279

Write-up:Initial and follow up information has been received from a vaccine coordinator concerning a female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of Gardasil (yeast). Subsequently, the patient experienced pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The patient sought unspecified medical attention. The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes." At the time of this report, the outcome of the events were unknown. Additional information has been requested. This is in follow-up to report (s) previously submitted on 12/14/2006. Initial and follow up information has been received from a vaccine coordinator concerning a 26 year old female who on 08-SEP-2006 was vaccinated in the left deltoid with the second 0.5 mL dose of GARDASIL (Lot # 654540/0800F). On 08-SEP-2006, the injection site area filled up with fluid with tennis ball size swelling per the patient. It was reported that the duration was "a couple hours". It was previously reported that the patient had developed pain at the injection site. It was reported that the vaccine hurt the patient more when injected into the arm rather than the upper thigh, hip area. It was reported that the "pain was so great that the patient said they would not finish the series". The shot was from a pre-filled safety syringe. The vaccine coordinator thinks "the pain may have something to do with the technique because the shots given from the single dose vials have not experienced as much pain". It was further reported that "she was unsure if the extreme pain was caused by the vaccine, injection site or the technique used with the safety syringes". The patient stated that this "was not a big deal but preferred the injection in her leg". At the time of this report, the outcome of the events were unknown. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=269195&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166